What is the recommended treatment for patients with a bioprosthetic aortic or mitral valve, a history of ischemic stroke or TIA before valve replacement, and no other indication for anticoagulation therapy beyond 3 to 6 months from the valve placement?
In these patients, long-term therapy with aspirin is recommended in preference to long-term anticoagulation to reduce the risk of recurrent stroke or TIA.